gnb 바로가기 본문 바로가기
Global Bio Forum 2024 New Paths to K-Drug Development

DateNov. 21(Thu) 08:30~15:45

PlaceConrad Seoul Park Ballroom (5th floor), Conrad Seoul, Yeouido, Seoul, Korea

09:00~09:20

Opening
Greetings
Congratulatory message

Yeong seop Lee CEO, News1

09:20~09:50

Special LectureThe Present and Future of Bio Ventures in the Republic of Korea

Soo Jin ChoiMember of the 22ndNational Assembly Republic of Korea

09:50~10:20

Key note Speech ①Innovative and Bold research and development initiative in Biohealth

Kyung SUNDirector General, K-Health MIRAE Initiative

10:20~10:40

Key note Speech ②Strategy for Korea BioHealth Industry as Future Growth Engine

Byung Geon (BG) RheeGI Innovation, Chairman & CEO

10:40~11:00

BIO Trend ①R&D open innovation strategy and a story of development of 3rd-generation EGFR inhibitor for NSCLC

Se-Woong OhVice President, Head of Research Institute, Yuhan Corporation

11:00~11:20

BIO Trend ②Two Drugs, Two Different Journeys

Hae In ShinVice President, Pipeline Value Up, SK Biopharmaceuticals

11:20~12:00

Discussion

Seung-kyou LeeVice President of KoreaBIO

Byung Geon (BG) RheeGI Innovation, Chairman & CEO

Se-Woong OhVice President, Head of Research Institute, Yuhan Corporation

Hae In ShinVice President, Pipeline Value Up, SK Biopharmaceuticals

Yeong Min ParkPresident & CEO Korea Drug Development Fund

12:00~13:20

Lunch Time

13:20~13:40

Key note Speech ③Guide to IPOs for Biotech companies

Aaron Seo Director General, Technology Company Listing Review, Korea Exchange

13:40~14:00

BIO Trend ③Framework of Pre-Submission Consultation for Innovative Products

Heesung KimDirector of Pre-Submission Consultation Division, Korea Ministry of Food and Drug Safety

14:00~14:45

IR Session

Park, Joo CheolCEO, HysensBio

Seong-Wook LeePresident & CEO, Rznomics Inc.

Sung Kil TakDOF Inc. CFO&COO

14:45~15:35

Discussion

Myung Kee KimCEO, LSK Investment

Aaron Seo Director General, Technology Company Listing Review, Korea Exchange

Heesung KimDirector of Pre-Submission Consultation Division, Korea Ministry of Food and Drug Safety

Soon ouk JungKorea Investment Partners, Director

Young-Hun LeSenior Director,, LSK Investment

Joo Cheol ParkCEO, HysensBio

15:35~15:45

Q&A

※ The above schedule is subject to change.